Moreover, MSCs could improve expression levels of survival-involved mammalian target of rapamycin (mTOR), 5′ AMP-activated protein kinase (AMPK), glycogen synthase kinase-3β (GSK-3β), Wnt3, and β-catenin in preclinical models of AD [96]. This evidence concerns the gene GSK3B and Alzheimer disease.